Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks (Thu, 28-Mar 7:10 AM ET)
Aptose Biosciences’ Strategic Shift to Front-Line AML Therapy Garners Buy Rating
TipRanks (Wed, 27-Mar 5:05 PM ET)
Aptose Biosciences GAAP EPS of -$7.58 beats by $0.40
Seeking Alpha News (Tue, 26-Mar 4:50 PM ET)
Aptose Biosciences Expands AML Treatment Trials
TipRanks (Tue, 26-Mar 4:38 PM ET)
Aptose Reports Results for the Fourth Quarter and Full Year 2023
Globe Newswire (Tue, 26-Mar 4:01 PM ET)
Aptose Biosciences Q4 2023 Earnings Preview
Seeking Alpha News (Mon, 25-Mar 5:20 PM ET)
Earnings week ahead: Walgreens Boots Alliance, Carnival, GameStop and more
Seeking Alpha News (Sun, 24-Mar 8:01 AM ET)
Globe Newswire (Mon, 18-Mar 4:30 PM ET)
Globe Newswire (Wed, 31-Jan 4:01 PM ET)
Globe Newswire (Fri, 26-Jan 8:00 AM ET)
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.
Aptose Biosciences - Common Shares trades on the NASDAQ stock market under the symbol APTO.
As of March 28, 2024, APTO stock price climbed to $1.66 with 134,673 million shares trading.
APTO has a beta of -0.46, meaning it tends to be less sensitive to market movements. APTO has a correlation of 0.00 to the broad based SPY ETF.
APTO has a market cap of $26.07 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, APTO stock traded as high as $96.90 and as low as $1.36.
APTO has underperformed the market in the last year with a return of -82.9%, while the SPY ETF gained +33.6%. In the last 3 month period, APTO fell short of the market, returning -35.2%, while SPY returned +10.1%. However, in the most recent 2 weeks APTO has outperformed the stock market by returning +15.3%, while SPY returned +1.7%.
APTO support price is $1.42 and resistance is $1.58 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that APTO stock will trade within this expected range on the day.